Matches in Nanopublications for { ?s ?p "DDI between Homoharringtonine and Tofacitinib - Avoid combination with tofacitinib and other potent immunosuppressants as there is potential to increase the immunosuppressant effects. Other less potent immunosuppressants such as methotrexate, at antirheumatic doses, and other non-disease modifying antirheumatic drugs (non-DMARDs) can be combined."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB04865_DB08895 title "DDI between Homoharringtonine and Tofacitinib - Avoid combination with tofacitinib and other potent immunosuppressants as there is potential to increase the immunosuppressant effects. Other less potent immunosuppressants such as methotrexate, at antirheumatic doses, and other non-disease modifying antirheumatic drugs (non-DMARDs) can be combined." assertion.